DR. CHRISTOPHER ANGELO SEQUEIRA M.D. NPI 1821309410

NPI Details

DR. Christopher Angelo Sequeira, M.D. is a medical oncology internal medicine in Winter Park, FL with 17 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Christopher Angelo Sequeira, M.D. NPI is 1821309410. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

460 N ORLANDO AVE
STE 200 BULG D
WINTER PARK, FL
ZIP 32789-988
Phone: (407) 898-5452
Fax: (407) 628-9529

The NPI 1821309410 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Red blood count, manual test (HCPCS:85044)
• Red blood count, automated test (HCPCS:85045)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Protein measurement, serum (HCPCS:84165)
• Folic acid level, serum (HCPCS:82746)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Automated urinalysis test (HCPCS:81003)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Erythropoietin (protein) level (HCPCS:82668)
• Magnesium level (HCPCS:83735)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Uric acid level, blood (HCPCS:84550)
• Blood test, clotting time (HCPCS:85610)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Hemoglobin analysis and measurement, electrophoresis (HCPCS:83020)
• Iron binding capacity (HCPCS:83550)

The enumeration date for this NPI number is 6/29/2010 and was last updated on 9/1/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.